1
|
Donelian A, Liu Z, Trager MH, Momen-Heravi F, Samie FH. Racial and ethnic disparities in basal cell carcinoma treated by Mohs micrographic surgery: the Columbia experience. Arch Dermatol Res 2024; 316:151. [PMID: 38734798 DOI: 10.1007/s00403-024-02858-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 02/02/2024] [Accepted: 04/07/2024] [Indexed: 05/13/2024]
Affiliation(s)
- Alec Donelian
- College of Dental Medicine, Columbia University, New York, NY, USA
| | - Zheyan Liu
- Department of Biostatistics, Columbia University, New York, NY, USA
| | - Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Fatemeh Momen-Heravi
- College of Dental Medicine, Columbia University, New York, NY, USA
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA.
| |
Collapse
|
2
|
Trager MH, Gordon ER, Humphreys TR, Samie FH. Part 1: Management of Antithrombotic Medications in Dermatologic Surgery. J Am Acad Dermatol 2024:S0190-9622(24)00736-9. [PMID: 38735483 DOI: 10.1016/j.jaad.2024.01.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 01/23/2024] [Accepted: 01/24/2024] [Indexed: 05/14/2024]
Abstract
Perioperative management of antithrombotic agents requires practical and medical considerations. Discontinuing antithrombotic therapies increases the risk of thrombotic adverse events including cerebrovascular accidents, myocardial infarction, pulmonary embolism, deep vein thrombosis, and retinal artery occlusion. Conversely, continuation of antithrombotic therapy during surgical procedures has associated bleeding risks. Currently, no guidelines exist regarding management of antithrombotic agents in the perioperative period for cutaneous surgeries and practice differs by surgeon. Here, we review the data on antithrombotic medications in patients undergoing cutaneous surgery including medication-specific surgical and postoperative bleeding risk if the medications are continued, and thromboembolic risk if the medications are interrupted. Specifically, we focus on vitamin K antagonist (VKA) (warfarin), direct-acting oral anticoagulants (DOAC) (rivaroxaban, apixaban, edoxaban, dabigatran), antiplatelet medications (aspirin, clopidogrel, prasugrel, ticagrelor, dipyridamole), unfractionated heparin, low molecular weight heparin (enoxaparin and dalteparin), fondaparinux, bruton tyrosine kinase inhibitors (BTKi) (ibrutinib, acalabrutinib), and dietary supplements (i.e., garlic, ginger, gingko).
Collapse
Affiliation(s)
- Megan H Trager
- Columbia University Irving Medical Center, Department of Dermatology
| | - Emily R Gordon
- Columbia University Vagelos College of Physicians and Surgeons
| | | | - Faramarz H Samie
- Columbia University Irving Medical Center, Department of Dermatology.
| |
Collapse
|
3
|
Desai AD, Ibrahim SJ, Samie FH. Evaluating the benefit of immunotherapy for Stage III melanoma. J Am Acad Dermatol 2024:S0190-9622(24)00679-0. [PMID: 38685406 DOI: 10.1016/j.jaad.2024.04.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Revised: 04/16/2024] [Accepted: 04/21/2024] [Indexed: 05/02/2024]
Affiliation(s)
- Amar D Desai
- Rutgers New Jersey Medical School, Newark, NJ, USA
| | - Sarah J Ibrahim
- Albert Einstein College of Medicine, New York, Bronx, NY, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
| |
Collapse
|
4
|
Pisano CE, Trager MH, Fan W, Samie FH. Surgical margins and outcomes for eyelid melanoma: a systematic review and meta-analysis. Arch Dermatol Res 2024; 316:106. [PMID: 38489027 DOI: 10.1007/s00403-024-02834-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Revised: 01/15/2024] [Accepted: 02/06/2024] [Indexed: 03/17/2024]
Abstract
No randomized trials exist to inform the peripheral surgical margins or depth of wide excision for eyelid melanoma. We performed a meta-analysis examining surgical margins and Breslow depth for eyelid melanomas. A systematic review was performed in August 2022 using PubMed, Cochrane, and Medline databases (1/1/1990 to 8/1/2022). Inclusion criteria included studies reporting surgical treatment of primary cutaneous melanomas of the eyelid with reported surgical margins. Ten articles were included. The studies were examined by surgical margin size (group 1: ≤ 0.5 cm; group 2 > 0.5 cm and ≤ 1.5 cm) and Breslow depth (group 1: ≤ 1 mm; group 2: > 1 mm). The odds ratio (OR) for local recurrence was 2.55 [95% CI 0.36-18.12], p = 0.18; regional metastasis was 0.70 [95% CI 0.00-23671.71], p = 0.48; and distant metastasis was 2.47 [95% CI 0.00-1687.43], p = 0.66. When examining by Breslow depth, the OR for local recurrence was 0.53 [95% CI 0.14-1.94], p = 0.34; regional metastasis was 0.14 [0.00-176.12], p = 0.54; and the OR for distant metastasis was 0.24 [95% CI 0.01-8.73], p = 0.46. There was a trend toward higher likelihood of recurrence and metastasis in the ≤ 0.5 cm group. Similarly, there is a trend toward higher likelihood of recurrence and metastasis with Breslow depth > 1 mm. A surgical margin of at least 0.5 cm and achievement of negative margins via permanent sections or MMS are likely needed to prevent adverse outcomes. En face sectioning may be a superior method of histological processing for eyelid melanoma.
Collapse
Affiliation(s)
| | - Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA.
| | - Weijia Fan
- Department of Biostatistics, Columbia University Mailman School of Public Health, New York, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| |
Collapse
|
5
|
Samie FH. JAAD Game Changer: Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2024; 90:584. [PMID: 37666423 DOI: 10.1016/j.jaad.2023.08.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Accepted: 08/28/2023] [Indexed: 09/06/2023]
|
6
|
Gordon ER, Trager MH, Kontos D, Weng C, Geskin LJ, Dugdale LS, Samie FH. Ethical Considerations for Artificial Intelligence in Dermatology: A Scoping Review. Br J Dermatol 2024:ljae040. [PMID: 38330217 DOI: 10.1093/bjd/ljae040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 12/26/2023] [Accepted: 02/06/2024] [Indexed: 02/10/2024]
Abstract
The field of dermatology is experiencing the rapid deployment of artificial intelligence (AI), from mobile applications for skin cancer detection to large language models like ChatGPT that can answer generalist or specialist questions about skin diagnoses. With these new applications, ethical concerns have emerged. In this scoping review, we aim to identify the applications of AI to the field of dermatology and to understand their ethical implications. We utilized a multifaceted search approach, searching PubMed, Medline, Cochrane, and Google Scholar for primary literature according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) Extension for Scoping Reviews. Our advanced query included terms related to dermatology, artificial intelligence, and ethical considerations. Our search yielded a total of 202 papers. After initial screening, 68 studies were included. Thirty-two related to clinical image analysis and raised ethical concerns for misdiagnosis, data security, violations of privacy, and replacement of dermatologist jobs. Seventeen discussed limited skin of color representation in datasets leading to potential misdiagnosis in the general population. Nine articles about teledermatology raised ethical concerns, including the exacerbation of health disparities, lack of standardized regulations, informed consent for AI use, and privacy challenges. Seven addressed inaccuracies of responses of large language models. Seven examined attitudes and trust towards AI, with most patients requesting supplemental assessment by a physician to ensure reliability and accountability. Benefits of artificial intelligence integration into clinical practice include increased patient access, improved clinical decision making, efficiency, and many others. However, safeguards must be implemented to ensure ethical applications of artificial intelligence.
Collapse
Affiliation(s)
- Emily R Gordon
- Columbia University Vagelos College of Physicians and Surgeons, New York, USA
| | - Megan H Trager
- Columbia University Irving Medical Center, Department of Dermatology, New York, USA
| | - Despina Kontos
- University of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, USA
- Columbia University Irving Medical Center, Department of Radiology, New York, USA
| | - Chunhua Weng
- Columbia University Irving Medical Center, Department of Biomedical Informatics, New York, USA
| | - Larisa J Geskin
- Columbia University Irving Medical Center, Department of Dermatology, New York, USA
| | - Lydia S Dugdale
- Columbia University Vagelos College of Physicians and Surgeons, Department of Medicine, Center for Clinical Medical Ethics, New York, USA
| | - Faramarz H Samie
- Columbia University Irving Medical Center, Department of Dermatology, New York, USA
| |
Collapse
|
7
|
Kassotis AS, Grimes J, Samie FH, Lewin JM, Levenson JA, Glass LRD. Risk factors for developing depressive symptoms in the immediate postoperative period after Mohs micrographic surgery. Orbit 2024; 43:22-27. [PMID: 36847522 DOI: 10.1080/01676830.2023.2179639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2022] [Accepted: 02/07/2023] [Indexed: 03/01/2023]
Abstract
PURPOSE Mohs micrographic surgery (MMS) is a highly efficacious, tissue sparing method of skin cancer removal. Nevertheless, in the months to years after MMS, psychosocial distress has been described. The present study addressed the immediate period after MMS and assessed the frequency and risk factors for development of depressive symptoms. METHODS Subjects undergoing MMS at two physician practices (JL, FS) were included in this prospective cohort study. Preoperatively, a standardized depression screening, the Patient Health Questionnaire-8 (PHQ-8), was administered. After MMS, the PHQ-8 was readministered at weeks 1, 2, 4, 6, and 12. Average PHQ-8 score by week and change from baseline PHQ-8 score were the primary outcomes. RESULTS Sixty-three subjects were included of which 49 (78%) had a facial site. Twenty-two subjects (35%) had some increase in score during the 12-week follow-up period, of which 18 had a facial site. The oldest subjects (83-99 years, n = 14) had significantly higher PHQ-8 scores at week 4 (p < 0.01) and week 6 (p = 0.02) than all other age groups. There were no differences in scores between location groups. CONCLUSIONS One-third of subjects had some increase in score during the follow-up period. Those in the oldest age cohort were at highest risk of increased score. In contrast to prior literature, those with facial sites were not at higher risk. This difference may be explained by increased masking during the ongoing COVID-19 pandemic. Ultimately, consideration of patients' psychologic status in the immediate postoperative period after MMS, particularly in the elderly population, may enhance perceived patient outcomes.
Collapse
Affiliation(s)
- Alexis S Kassotis
- Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA
| | - Joseph Grimes
- Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Jesse M Lewin
- The Kimberly and Eric J. Waldman Department of Dermatology, Ichan School of Medicine at Mt. Sinai, New York, NY, USA
| | - Jon A Levenson
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA
| | - Lora R Dagi Glass
- Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA
| |
Collapse
|
8
|
Fahmy LM, Dowd ML, Loesch E, Denson EM, Pisano CE, Samie FH. Postoperative Bleeding Complications Associated With Novel Oral Anticoagulants in Mohs Micrographic Surgery. Dermatol Surg 2024; 50:1-4. [PMID: 37792670 DOI: 10.1097/dss.0000000000003967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/06/2023]
Abstract
BACKGROUND Novel oral anticoagulants (NOACs) are commonly prescribed, recently developed anticoagulants, but limited data exist on NOAC-related bleeding complications in Mohs micrographic surgery (MMS). OBJECTIVE To assess the risk of postoperative bleeding in patients taking NOACs compared with patients taking no antithrombotic medications. METHODS/MATERIALS A 5-year retrospective chart review of all MMS cases performed by a single surgeon was conducted. Patient and surgery characteristics, anticoagulant use, and bleeding complications were recorded. RESULTS Two thousand one hundred eighty-one MMS cases in 1,545 patients were included. There were 696/2,181 cases in which patients were taking at least 1 antithrombotic medication, with 149 on NOAC monotherapy and 15 on NOAC and aspirin combination therapy. Bleeding complications occurred in 22/2,181 cases. Patients on NOAC monotherapy did not have an increased risk of bleeding complications compared with patients on no antithrombotic medications (odds ratio [OR]:1.70, 95% confidence interval [CI]: 0.36-7.97, p = .50). In contrast, patients on NOAC and aspirin combination therapy exhibited an increased bleeding risk (OR: 20.5, 95% CI: 3.99-105.7, p < .001). CONCLUSION Novel oral anticoagulant use alone during MMS was not associated with an increased postoperative bleeding risk, supporting the safety of continuing NOAC therapy during MMS. However, NOAC and aspirin combination therapy was associated with a high postoperative bleeding risk. Nonetheless, these bleeding events did not lead to adverse long-term outcomes.
Collapse
Affiliation(s)
- Lauren M Fahmy
- Columbia University Vagelos College of Physicians and Surgeons, New York, New York
| | - Margaret L Dowd
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
- Mohs Surgery and Cutaneous Oncology, Bassett Healthcare Network, Cooperstown, New York
| | - Eric Loesch
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Elizabeth M Denson
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Catherine E Pisano
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| |
Collapse
|
9
|
Trager MH, Queen D, Denson E, Fan W, Youssef S, Samie FH. Pre-operative drawings of anticipated closures as a visual tool to align patient and physician expectations for Mohs and reconstructive surgery. Arch Dermatol Res 2023; 316:45. [PMID: 38103050 DOI: 10.1007/s00403-023-02774-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2023] [Revised: 10/21/2023] [Accepted: 11/09/2023] [Indexed: 12/17/2023]
Affiliation(s)
- Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA.
| | - Dawn Queen
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Elizabeth Denson
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Weijia Fan
- Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA
| | - Soundos Youssef
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| |
Collapse
|
10
|
Trager MH, Queen D, Bordone LA, Geskin LJ, Samie FH. Assessing ChatGPT responses to common patient queries regarding basal cell carcinoma. Arch Dermatol Res 2023; 315:2979-2981. [PMID: 37668714 DOI: 10.1007/s00403-023-02705-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 07/28/2023] [Accepted: 08/13/2023] [Indexed: 09/06/2023]
Affiliation(s)
- Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Dawn Queen
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Lindsey A Bordone
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Larisa J Geskin
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, Herbert Irving Pavilion, 12th Floor, New York, NY, 10032, USA.
| |
Collapse
|
11
|
Desai AD, Behbahani S, Soliman Y, Samie FH. Factors associated with Mohs micrographic surgery in dermatofibrosarcoma protuberans of the head and neck: A cohort study. Indian J Dermatol Venereol Leprol 2023; 0:1-3. [PMID: 37436022 DOI: 10.25259/ijdvl_991_2022] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 05/12/2023] [Indexed: 07/13/2023]
Affiliation(s)
- Amar D Desai
- Department of Dermatology, Rutgers New Jersey Medical School, Newark, NJ
| | - Sara Behbahani
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA
| | - Yssra Soliman
- Department of Dermatology, Columbia University Irving Medical Center, NY
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, NY
| |
Collapse
|
12
|
Rust DJ, Kwinta BD, Geskin LJ, Samie FH, Remotti F, Yoon SS. Surgical management of dermatofibrosarcoma protuberans. J Surg Oncol 2023. [PMID: 36999599 DOI: 10.1002/jso.27258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Revised: 02/08/2023] [Accepted: 03/09/2023] [Indexed: 04/01/2023]
Abstract
Dermatofibrosarcoma protuberans (DFSP) is an uncommon, locally aggressive cutaneous malignancy. Complete resection is the primary treatment but there is debate over the optimal method. Wide local excision was traditionally the standard of care; however, National Comprehensive Cancer Network guidelines now recommend Mohs micrographic surgery as the preferred approach. Medical therapy with imatinib can be used in advanced or unresectable disease. This review will discuss the current management of DFSP, focusing on optimal surgical approach.
Collapse
Affiliation(s)
- Dylan J Rust
- Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA
- Department of Surgery, Division of Surgical Oncology, Columbia University Irving Medical Center, New York, New York, USA
| | - Bradley D Kwinta
- Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| | - Larisa J Geskin
- Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| | - Faramarz H Samie
- Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| | - Fabrizio Remotti
- Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA
- Division of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA
| | - Sam S Yoon
- Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA
- Department of Surgery, Division of Surgical Oncology, Columbia University Irving Medical Center, New York, New York, USA
| |
Collapse
|
13
|
Samie FH. JAAD Game Changers: Tangential excision of pigmented nail matrix lesions responsible for longitudinal melanonychia: Evaluation of the technique on a series of 30 patients. J Am Acad Dermatol 2023; 88:518. [PMID: 31129218 DOI: 10.1016/j.jaad.2019.05.038] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2019] [Accepted: 05/16/2019] [Indexed: 01/17/2023]
|
14
|
Samie FH. JAAD Game Changers: A prospective observational study evaluating hypothalamic-pituitary-adrenal axis alteration and efficacy of intramuscular triamcinolone acetonide for steroid-responsive dermatologic disease. J Am Acad Dermatol 2023; 88:516. [PMID: 31809820 DOI: 10.1016/j.jaad.2019.11.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2019] [Accepted: 11/22/2019] [Indexed: 01/17/2023]
|
15
|
Samie FH. JAAD Game Changers: Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study. J Am Acad Dermatol 2023; 88:515. [PMID: 31809815 DOI: 10.1016/j.jaad.2019.11.048] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2019] [Accepted: 11/22/2019] [Indexed: 01/17/2023]
|
16
|
Desai AD, Behbahani S, Samie FH. Predictors of Time to Definitive Surgery and Survival in Merkel Cell Carcinoma: Analysis of National Cancer Database. Clin Exp Dermatol 2022; 47:1275-1282. [PMID: 35150153 DOI: 10.1111/ced.15133] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Revised: 02/03/2022] [Accepted: 02/07/2022] [Indexed: 11/30/2022]
Abstract
BACKGROUND Effects of delays in treatment for Merkel cell carcinoma (MCC) are not yet fully understood. OBJECTIVES To determine the effect of time to treatment initiation (TTI) on mortality in MCC and predictors of TTI itself. METHODS Retrospective cohort analysis of the National Cancer Database (NCDB) for cases of MCC from 2004-2016, excluding individuals with Stage IV MCC as surgery is not the preferred treatment for this group. RESULTS A total of 12,157 patients (average age:74.4 years, SD:10.9) were included in the study, 7,491(61.6%) were male and 4,666 (38.4%) were female. Risk of higher TTI was seen in Blacks (odds ratio [OR]:1.7, 95% CI:1.2,2.6) and elderly individuals over 70 years (OR:1.7, 95% CI:1.2,2.5). On Kaplan-Meier survival analysis, individuals with TTI <30 days had a significantly longer overall survival than those with TTI >120 days (6.1 vs. 4.8 years, p=0.0002). However, after controlling for clinical and tumor factors in Cox multivariable analysis, no difference in survival was noted for TTI <30 days and TTI >120 days (Hazard Ratio [HR]:0.9, 95% CI:0.8,1.1). Worse outcomes were also associated with increasing age (HR:2.0, 95% CI:1.7,2.5), male sex (HR:1.2, 95% CI:1.2-1.3), higher CDCC (HR:1.4, 95% CI:1.3,1.5), lack of radiation therapy (HR:0.8, 95% CI:0.8-0.9), lack of private insurance (HR:0.7, 95% CI:0.6-1.0), and surgical technique other than Mohs or WLE (HR:1.2, 95% CI:1.2-1.3). CONCLUSIONS Although TTI is a useful prognostic metric in isolated survival analysis, its utility declines when controlling for other factors. Age, radiotherapy, type of surgery performed, co-morbidities, tumor size, and lymph node involvement may be important predictors of survival.
Collapse
Affiliation(s)
- Amar D Desai
- Rutgers New Jersey Medical School, Newark, NJ, USA
| | - Sara Behbahani
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.,Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| |
Collapse
|
17
|
Queen D, Trager MH, Fan W, Samie FH. Patient Satisfaction of General Dermatology Providers: A Quantitative and Qualitative Analysis of 38,008 Online Reviews. JID Innov 2021; 1:100049. [PMID: 34909746 PMCID: PMC8659734 DOI: 10.1016/j.xjidi.2021.100049] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Revised: 06/17/2021] [Accepted: 06/18/2021] [Indexed: 11/25/2022] Open
Abstract
Measuring patient satisfaction of general dermatology providers is an important goal because it can lead to improved clinical outcomes. Online reviews are emerging as the newest forum for evaluating physicians in real time and provide a valuable tool for measuring patient satisfaction. We analyzed both quantitative and qualitative online reviews of general dermatology providers at 121 Accreditation Council for Graduate Medical Education‒accredited dermatology programs across the country to determine which elements are most discussed in online ratings using the online platforms Vitals, US News, WebMD, Google Reviews, and Healthgrades. There were 38,008 online reviews included from general dermatology providers at Accreditation Council for Graduate Medical Education‒accredited programs. The median average overall quantitative rating of providers was 4.35 of 5. There were more positive (77%) than negative (23%) comments. The overall ratings of general dermatology providers were favorable. The most influential factors in both positive and negative comments were patient’s perceived experience and physician’s bedside manner (26% and 17%, respectively). Less important factors included office space, treatment by auxiliary staff, wait time, costs, and time spent with patients. This suggests that a provider’s personality, expressed compassion, empathy, and kindness may overcome other issues and create an overall positive experience.
Collapse
Affiliation(s)
- Dawn Queen
- Department of Medicine, Lankenau Medical Center, Main Line Health, Philadelphia, Pennsylvania, USA.,Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| | - Megan H Trager
- Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA
| | - Weijia Fan
- Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| |
Collapse
|
18
|
Ensslin CJ, Samie FH, Lewin JM. Repair of a Full-Thickness Defect of the Nasal Root and Sidewall. Dermatol Surg 2021; 47:1651-1653. [PMID: 33038104 DOI: 10.1097/dss.0000000000002821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Courtney J Ensslin
- All authors are affiliated with the Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | | | | |
Collapse
|
19
|
Massey PR, Schmults CD, Li SJ, Arron ST, Asgari MM, Bavinck JNB, Billingsley E, Blalock TW, Blasdale K, Carroll BT, Carucci JA, Chong AH, Christensen SR, Chung CL, DeSimone JA, Ducroux E, Escutia-Muñoz B, Ferrándiz-Pulido C, Fox MC, Genders RE, Geusau A, Gjersvik P, Hanlon AM, Harken EBO, Hofbauer GF, Hopkins RS, Leitenberger JJ, Loss MJ, Del Marmol V, Mascaró JM, Myers SA, Nguyen BT, Oliveira WRP, Otley CC, Proby CM, Rácz E, Ruiz-Salas V, Samie FH, Seçkin D, Shah SN, Shin TM, Shumack SP, Soon SL, Stasko T, Zavattaro E, Zeitouni NC, Zwald FO, Harwood CA, Jambusaria-Pahlajani A. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement. JAMA Dermatol 2021; 157:1219-1226. [PMID: 34468690 PMCID: PMC9937447 DOI: 10.1001/jamadermatol.2021.3180] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
IMPORTANCE There is a paucity of evidence to guide physicians regarding prevention strategies for cutaneous squamous cell carcinoma (CSCC) in solid organ transplant recipients (SOTRs). OBJECTIVE To examine the development and results of a Delphi process initiated to identify consensus-based medical management recommendations for prevention of CSCC in SOTRs. EVIDENCE REVIEW Dermatologists with more than 5 years' experience treating SOTRs were invited to participate. A novel actinic damage and skin cancer index (AD-SCI), consisting of 6 ordinal stages corresponding to an increasing burden of actinic damage and CSCC, was used to guide survey design. Three sequential web-based surveys were administered from January 1, 2019, to December 31, 2020. Pursuant to Delphi principles, respondents thoroughly reviewed all peer responses between rounds. Supplemental questions were also asked to better understand panelists' rationale for their responses. FINDINGS The Delphi panel comprised 48 dermatologists. Respondents represented 13 countries, with 27 (56%) from the US. Twenty-nine respondents (60%) were Mohs surgeons. Consensus was reached with 80% or higher concordance among respondents when presented with a statement, question, or management strategy pertaining to prevention of CSCC in SOTRs. A near-consensus category of 70% to less than 80% concordance was also defined. The AD-SCI stage-based recommendations were established if consensus or near-consensus was achieved. The panel was able to make recommendations for 5 of 6 AD-SCI stages. Key recommendations include the following: cryotherapy for scattered actinic keratosis (AK); field therapy for AK when grouped in 1 anatomical area, unless AKs are thick in which case field therapy and cryotherapy were recommended; combination lesion directed and field therapy with fluorouracil for field cancerized skin; and initiation of acitretin therapy and discussion of immunosuppression reduction or modification for patients who develop multiple skin cancers at a high rate (10 CSCCs per year) or develop high-risk CSCC (defined by a tumor with approximately ≥20% risk of nodal metastasis). No consensus recommendation was achieved for SOTRs with a first low risk CSCC. CONCLUSIONS AND RELEVANCE Physicians may consider implementation of panel recommendations for prevention of CSCC in SOTRs while awaiting high-level-of-evidence data. Additional clinical trials are needed in areas where consensus was not reached.
Collapse
Affiliation(s)
- Paul R. Massey
- Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
| | - Chrysalyne D. Schmults
- Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
| | - Sara J. Li
- Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
| | - Sarah T. Arron
- Sarah Arron MD, A Professional Corporation, San Mateo, California
| | - Maryam M. Asgari
- Department of Dermatology, Massachusetts General Hospital, Boston,Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts
| | | | | | - Travis W. Blalock
- Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia
| | - Katie Blasdale
- Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
| | - Bryan T. Carroll
- Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio,Department of Dermatology, Case Western Reserve University, Cleveland, Ohio
| | - John A. Carucci
- The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York
| | - Alvin H. Chong
- Skin Health Institute, Victoria, Australia,Department of Medicine (Dermatology), St Vincent’s Hospital Clinical School, The University of Melbourne, Victoria, Australia
| | - Sean R. Christensen
- Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut
| | - Christina Lee Chung
- Montgomery Dermatology, King of Prussia, Pennsylvania,Lankenau Institute for Medical Research, Wynnewood, Pennsylvania
| | | | - Emilie Ducroux
- Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, France
| | | | - Carla Ferrándiz-Pulido
- Department of Dermatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain,Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Matthew C. Fox
- Division of Dermatology, Dell Medical School, University of Texas at Austin, Austin
| | - Roel E. Genders
- Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands
| | - Alexandra Geusau
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - Petter Gjersvik
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway,Department of Dermatology, Oslo University Hospital, Oslo, Norway
| | - Allison M. Hanlon
- Department of Dermatology, Vanderbilt University, Nashville, Tennessee
| | | | | | - R. Samuel Hopkins
- Department of Dermatology, Oregon Health and Science University, Portland
| | | | - Manisha J. Loss
- Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland
| | - Veronique Del Marmol
- Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - José M. Mascaró
- Department of Dermatology, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
| | - Sarah A. Myers
- Department of Dermatology, Duke University, Durham, North Carolina
| | - Bichchau T. Nguyen
- Department of Dermatology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts,Department of Dermatology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts
| | - Walmar R. P. Oliveira
- Department of Dermatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
| | - Clark C. Otley
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota
| | - Charlotte M. Proby
- Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom
| | - Emőke Rácz
- Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Veronica Ruiz-Salas
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - Faramarz H. Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Deniz Seçkin
- Department of Dermatology, Başkent University Faculty of Medicine, Ankara, Turkey
| | - Syed N. Shah
- Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom
| | - Thuzar M. Shin
- Department of Dermatology, University of Pennsylvania, Philadelphia
| | | | - Seaver L. Soon
- Scripps Green Hospital, Private Practice (The Skin Clinic MD), San Diego, California
| | - Thomas Stasko
- Department of Dermatology, University of Oklahoma Health Sciences Center, Oklahoma City
| | - Elisa Zavattaro
- Dermatology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy
| | - Nathalie C. Zeitouni
- Medical Dermatology Specialists, Phoenix, Arizona,Division of Dermatology, University of Arizona College of Medicine, Phoenix
| | - Fiona O’Reilly Zwald
- Piedmont Healthcare, Atlanta, Georgia,O’Reilly Comprehensive Dermatology Inc, Atlanta, Georgia,Mount Vernon Medical Center, Atlanta, Georgia
| | - Catherine A. Harwood
- Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts, United Kingdom,The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
| | | |
Collapse
|
20
|
Shim PJ, Dowd ML, Kang P, Samie FH, Zeitouni NC. Reflectance confocal microscopy detects residual or recurrent lentigo maligna after surgery. Australas J Dermatol 2021; 62:521-523. [PMID: 34423845 DOI: 10.1111/ajd.13693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 08/02/2021] [Accepted: 08/04/2021] [Indexed: 11/29/2022]
Affiliation(s)
- Paul J Shim
- University of Arizona College of Medicine, Phoenix, Arizona, USA
| | - Margaret L Dowd
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Paul Kang
- University of Arizona College of Public Health, Phoenix, Arizona, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Nathalie C Zeitouni
- University of Arizona College of Medicine, Phoenix, Arizona, USA.,Medical Dermatology Specialists, Phoenix, Arizona, USA
| |
Collapse
|
21
|
Trager MH, Coley SM, Dube G, Khan S, Ingham M, Samie FH, Geskin LJ, McDonnell D, Brouder D, Saenger Y, Carvajal R. Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients. J Immunother Cancer 2021; 8:jitc-2020-000908. [PMID: 32503950 PMCID: PMC7279669 DOI: 10.1136/jitc-2020-000908] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/05/2020] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Immune checkpoint blockade has emerged as a highly effective treatment for patients with metastatic melanoma and cutaneous squamous cell carcinoma. Nivolumab blocks the interactions between programmed cell death protein 1 and programmed death ligand 1 allowing for activation of a latent immune response against the malignancy. Ipilimumab binds to and blocks cytotoxic T-lymphocyte-associated protein 4, alleviating the negative regulation of T-cell activation that is mediated by that checkpoint. Combination therapy with nivolumab and ipilimumab is associated with longer overall survival at 5 years compared with nivolumab monotherapy. Solid organ transplant recipients have a significantly higher risk of malignancies compared with the general population. There is limited data surrounding the efficacy of combination immunotherapy in solid organ transplant recipients, as these patients were excluded from seminal trials due to risk of organ rejection. CASE PRESENTATIONS Here we present four cases of combination immunotherapy in kidney transplant recipients. Three patients had metastatic melanoma, and one patient had metastatic cutaneous squamous cell carcinoma. Two patients had radiographic responses from immunotherapy, one patient had stable disease, and one patient had disease progression. Only one patient had biopsy-proven rejection. At last follow-up, three patients had functioning grafts, though one required hemodialysis after treatment, and one patient succumbed to disease, but graft function remained intact throughout her course. CONCLUSIONS These cases describe the use of ipilimumab and nivolumab combination immunotherapy for cutaneous malignancies in kidney transplant recipients. They highlight the potential to preserve kidney graft function while effectively treating the disease. TRIAL REGISTRATION NUMBER NCT03816332.
Collapse
Affiliation(s)
- Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| | - Shana M Coley
- Department of Pathology and Cell Biology, Division of Renal Pathology, Columbia University Irving Medical Center, New York, New York, USA
| | - Geoffrey Dube
- Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA
| | - Shaheer Khan
- Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA
| | - Matthew Ingham
- Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| | - Larisa J Geskin
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York, USA
| | - Diana McDonnell
- Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA
| | | | - Yvonne Saenger
- Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA
| | - Richard Carvajal
- Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA
| |
Collapse
|
22
|
Affiliation(s)
- Mardeen S Karim
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - Courtney J Ensslin
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - Margaret L Dowd
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Medical Center, New York, New York
| |
Collapse
|
23
|
Alam M, Harikumar V, Kang BY, Ibrahim SA, Kibbi N, Owen JL, Maher IA, Cartee TV, Sobanko JF, Reynolds KA, Bolotin D, Waldman AH, Minkis K, Petersen B, Council ML, Nehal KS, Xu YG, Jiang SB, Somani AK, Bichakjian CK, Huang CC, Eisen DB, Ozog DM, Lee EH, Samie FH, Neuhaus IM, Bordeaux JS, Wang JV, Leitenberger JJ, Mann MW, Lawrence N, Zeitouni NC, Golda N, Behshad R, Ibrahim SF, Yu SS, Shin TM, Stebbins WG, Worley B. Development of international clinical practice guidelines: benefits, limitations, and alternative forms of international collaboration. Arch Dermatol Res 2020; 314:483-486. [PMID: 33216212 DOI: 10.1007/s00403-020-02166-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 10/30/2020] [Accepted: 11/03/2020] [Indexed: 02/07/2023]
Affiliation(s)
- Murad Alam
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA.
| | - Vishnu Harikumar
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Bianca Y Kang
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Sarah A Ibrahim
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Nour Kibbi
- Department of Dermatology, Stanford University School of Medicine, Redwood, CA, USA
| | - Joshua L Owen
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA.,South Texas Skin Cancer Center, San Antonio, TX, USA
| | - Ian A Maher
- Department of Dermatology, University of Minnesota, Minneapolis, MN, USA
| | - Todd V Cartee
- Department of Dermatology, Penn State College of Medicine, Hershey, PA, USA
| | - Joseph F Sobanko
- Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Kelly A Reynolds
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Diana Bolotin
- Section of Dermatology, The University of Chicago, Chicago, IL, USA
| | - Abigail H Waldman
- Brigham and Women's Hospital Department of Dermatology, Harvard Medical School, Boston, MA, USA
| | - Kira Minkis
- Department of Dermatology, Weill-Cornell Medical College, New York, NY, USA
| | - Brian Petersen
- Department of Dermatology, Colorado Permanente Medical Group, Denver, CO, USA
| | - M Laurin Council
- Division of Dermatology, Center for Dermatologic and Cosmetic Surgery, Washington University in Saint Louis, Saint Louis, MO, USA
| | - Kishwer S Nehal
- Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Y Gloria Xu
- Department of Dermatology, University of Wisconsin-Madison, Madison, WI, USA
| | - S Brian Jiang
- Department of Dermatology, University of California San Diego, San Diego, CA, USA
| | - Ally-Khan Somani
- Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA
| | | | - Conway C Huang
- Department of Dermatology, University of Alabama, Birmingham, AL, USA
| | - Daniel B Eisen
- Department of Dermatology, University of California Davis, Sacramento, CA, USA
| | - David M Ozog
- Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA
| | - Erica H Lee
- Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Isaac M Neuhaus
- Department of Dermatology, University of California At San Francisco, San Francisco, CA, USA
| | - Jeremy S Bordeaux
- Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.,Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
| | - Jordan V Wang
- Laser and Skin Surgery Center of New York, New York, NY, USA
| | | | - Margaret W Mann
- Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.,Innova Dermatology, Hendersonville, TN, USA
| | - Naomi Lawrence
- Division of Dermatology, Section of Procedural Dermatology, Cooper Hospital, Rowan University, Camden, NJ, USA
| | | | - Nicholas Golda
- Department of Dermatology, University of Missouri School of Medicine, Columbia, MO, USA
| | - Ramona Behshad
- Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO, USA
| | - Sherrif F Ibrahim
- Department of Dermatology, University of Rochester, Rochester, NY, USA
| | - Siegrid S Yu
- Department of Dermatology, University of California At San Francisco, San Francisco, CA, USA
| | - Thuzar M Shin
- Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - William G Stebbins
- Department of Dermatology, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Brandon Worley
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| |
Collapse
|
24
|
Alam M, Harikumar V, Ibrahim SA, Kang BY, Maher IA, Cartee TV, Sobanko JF, Kibbi N, Owen JL, Reynolds KA, Bolotin D, Waldman AH, Minkis K, Petersen B, Council ML, Nehal KS, Xu YG, Jiang SB, Somani AK, Bichakjian CK, Huang CC, Eisen DB, Ozog DM, Lee EH, Samie FH, Neuhaus IM, Bordeaux JS, Wang JV, Leitenberger JJ, Mann MW, Lawrence N, Zeitouni NC, Golda N, Behshad R, Ibrahim SF, Yu SS, Shin TM, Stebbins WG, Worley B. Principles for developing and adapting clinical practice guidelines and guidance for pandemics, wars, shortages, and other crises and emergencies: the PAGE criteria. Arch Dermatol Res 2020; 314:393-398. [PMID: 33206210 DOI: 10.1007/s00403-020-02167-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 10/30/2020] [Accepted: 11/03/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Murad Alam
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA.
| | - Vishnu Harikumar
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Sarah A Ibrahim
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Bianca Y Kang
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Ian A Maher
- Department of Dermatology, University of Minnesota, Minneapolis, MN, USA
| | - Todd V Cartee
- Department of Dermatology, Penn State College of Medicine, Hershey, PA, USA
| | - Joseph F Sobanko
- Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Nour Kibbi
- Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA
| | - Joshua L Owen
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA.,South Texas Skin Cancer Center, San Antonio, TX, USA
| | - Kelly A Reynolds
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| | - Diana Bolotin
- Section of Dermatology, The University of Chicago, Chicago, IL, USA
| | - Abigail H Waldman
- Brigham and Women's Hospital Department of Dermatology, Harvard Medical School, Boston, MA, USA
| | - Kira Minkis
- Department of Dermatology, Weill-Cornell Medical College, New York, NY, USA
| | - Brian Petersen
- Department of Dermatology, Colorado Permanente Medical Group, Denver, CO, USA
| | - M Laurin Council
- Division of Dermatology, Center for Dermatologic and Cosmetic Surgery, Washington University in Saint Louis, Saint Louis, MO, USA
| | - Kishwer S Nehal
- Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Y Gloria Xu
- Department of Dermatology, University of Wisconsin-Madison, Madison, WI, USA
| | - S Brian Jiang
- Department of Dermatology, University of California San Diego, San Diego, CA, USA
| | - Ally-Khan Somani
- Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA
| | | | - Conway C Huang
- Department of Dermatology, University of Alabama, Birmingham, AL, USA
| | - Daniel B Eisen
- Department of Dermatology, University of California Davis, Sacramento, CA, USA
| | - David M Ozog
- Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA
| | - Erica H Lee
- Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Isaac M Neuhaus
- Department of Dermatology, University of California at San Francisco, San Francisco, CA, USA
| | - Jeremy S Bordeaux
- Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.,Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
| | - Jordan V Wang
- Laser and Skin Surgery Center of New York, New York, NY, USA
| | | | - Margaret W Mann
- Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.,Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
| | - Naomi Lawrence
- Division of Dermatology, Section of Procedural Dermatology, Cooper Hospital, Rowan University, Camden, NJ, USA
| | | | - Nicholas Golda
- Department of Dermatology, University of Missouri School of Medicine, Columbia, MO, USA
| | - Ramona Behshad
- Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO, USA
| | - Sherrif F Ibrahim
- Department of Dermatology, University of Rochester, Rochester, NY, USA
| | - Siegrid S Yu
- Department of Dermatology, University of California at San Francisco, San Francisco, CA, USA
| | - Thuzar M Shin
- Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - William G Stebbins
- Department of Dermatology, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Brandon Worley
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 1600, Chicago, IL, 60611, USA
| |
Collapse
|
25
|
Strom MA, Trager MH, Timerman D, Coromilas AJ, Burris K, Belsito DV, Eber A, Greenberg S, Husain S, Lewin JM, Naka F, Patrone CC, Coulon A, Cooper C, Bartholomew FB, Beck M, Dowd ML, Ensslin C, Gallitano SM, Loesch E, Malajian DM, Melnick L, Niedt GW, Uwakwe LN, Vu HL, Walther RR, Samie FH, Geskin LJ. Cutaneous findings in hospitalized and critically ill patients with COVID-19: A case series of 15 patients. J Am Acad Dermatol 2020; 84:510-511. [PMID: 33068643 PMCID: PMC7554488 DOI: 10.1016/j.jaad.2020.10.014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Revised: 08/26/2020] [Accepted: 10/06/2020] [Indexed: 11/25/2022]
Affiliation(s)
- Mark A Strom
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Dmitriy Timerman
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Alexandra J Coromilas
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Katy Burris
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Donald V Belsito
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Ariel Eber
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Sophie Greenberg
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Sameera Husain
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Jesse M Lewin
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Fludiona Naka
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Christina C Patrone
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Aaron Coulon
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Chelsea Cooper
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | | | - Melissa Beck
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Margaret L Dowd
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Courtney Ensslin
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Stephanie M Gallitano
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Eric Loesch
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Dana M Malajian
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Laura Melnick
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - George W Niedt
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Laura N Uwakwe
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Ha Linh Vu
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Robert R Walther
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Larisa J Geskin
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
| |
Collapse
|
26
|
Behbahani S, Malerba S, Warren CJ, Pomeranz MK, Samie FH. Melanoma in situ and invasive melanoma of the vulva: An analysis of the National Cancer Database. J Am Acad Dermatol 2020; 84:1744-1749. [PMID: 32950551 DOI: 10.1016/j.jaad.2020.09.036] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Revised: 09/03/2020] [Accepted: 09/04/2020] [Indexed: 10/23/2022]
Affiliation(s)
| | | | | | - Miriam K Pomeranz
- The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
| |
Collapse
|
27
|
Ensslin CJ, Fisher J, Samie FH. Modification of the Staged Retroauricular Flap for Repair of Midhelical Defects. Facial Plast Surg 2020; 36:493-494. [PMID: 32866984 DOI: 10.1055/s-0039-3401021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- Courtney J Ensslin
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - Juliya Fisher
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Medical Center, New York, New York
| |
Collapse
|
28
|
Queen D, Shen Y, Trager MH, Lopez AT, Samie FH, Lewin JM, Niedt GW, Geskin LJ, Liu L. UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes. FASEB J 2020; 34:13022-13032. [PMID: 32776588 DOI: 10.1096/fj.202001412r] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 07/08/2020] [Accepted: 07/27/2020] [Indexed: 11/11/2022]
Abstract
Currently, there is no sensitive molecular test for identifying transformation-prone actinic keratoses (AKs) and aggressive squamous cell carcinoma (SCC) subtypes. Biomarker-based molecular testing represents a promising tool for risk stratifying these lesions. We evaluated the utility of a panel of ultraviolet (UV) radiation-biomarker genes in distinguishing between benign and transformation-prone AKs and SCCs. The expression of the UV-biomarker genes in 31 SCC and normal skin (NS) pairs and 10 AK/NS pairs was quantified using the NanoString nCounter system. Biomarker testing models were built using logistic regression models with leave-one-out cross validation in the training set. The best model to classify AKs versus SCCs (area under curve (AUC) 0.814, precision score 0.833, recall 0.714) was constructed using a top-ranked set of 13 UV-biomarker genes. Another model based on a 15-gene panel was developed to differentiate histologically concerning from less concerning SCCs (AUC 1, precision score 1, recall 0.714). Finally, 12 of the UV-biomarker genes were differentially expressed between AKs and SCCs, while 10 genes were uniquely expressed in the more concerning SCCs. UV-biomarker gene subsets demonstrate dynamic utility as molecular tools to classify and risk stratify AK and SCC lesions, which will complement histopathologic diagnosis to guide treatment of high-risk patients.
Collapse
Affiliation(s)
- Dawn Queen
- Department of Medicine, Lankenau Medical Center, Philadelphia, PA, USA
| | - Yao Shen
- Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA
| | - Megan H Trager
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
| | - Adriana T Lopez
- Department of Dermatology, New York University, New York, NY, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Jesse M Lewin
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - George W Niedt
- Department of Pathology, Columbia University Irving Medical Center, New York, NY, USA
| | - Larisa J Geskin
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Liang Liu
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.,The Hormel Institute, University of Minnesota, Austin, MN, USA
| |
Collapse
|
29
|
Trager MH, Geskin LJ, Samie FH, Liu L. Biomarkers in melanoma and non‐melanoma skin cancer prevention and risk stratification. Exp Dermatol 2020; 31:4-12. [DOI: 10.1111/exd.14114] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2020] [Accepted: 05/10/2020] [Indexed: 02/06/2023]
Affiliation(s)
- Megan H. Trager
- Department of Dermatology Columbia University Irving Medical Center New York NYUSA
| | - Larisa J. Geskin
- Department of Dermatology Columbia University Irving Medical Center New York NYUSA
| | - Faramarz H. Samie
- Department of Dermatology Columbia University Irving Medical Center New York NYUSA
| | - Liang Liu
- The Hormel Institute University of Minnesota Austin MNUSA
| |
Collapse
|
30
|
Fisher J, Zeitouni N, Fan W, Samie FH. Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review. J Am Acad Dermatol 2020; 82:1490-1500. [DOI: 10.1016/j.jaad.2019.07.005] [Citation(s) in RCA: 68] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Revised: 06/12/2019] [Accepted: 07/03/2019] [Indexed: 02/06/2023]
|
31
|
Abstract
Conjunctival melanoma is a rare tumor of the conjunctival epithelium with a heterogenous clinical presentation and a propensity for regional and distant metastatic spread. Guidelines for the treatment of local conjunctival melanoma are well-established, but there are no standard efficacious therapies for metastatic disease. Given that conjunctival melanoma is genetically similar to cutaneous melanoma and mucosal melanomas, targeted therapies effective in the treatment of these diseases, such as BRAF inhibitors and KIT inhibitors, may be effective in the treatment of patients with metastatic conjunctival melanoma. Other targeted small-molecule drugs in the drug development pipeline for the treatment of more prevalent melanomas could also be applicable to conjunctival melanoma. Furthermore, systemic immunotherapy treatments that are now a mainstay in the treatment of cutaneous melanoma, such as programmed cell death-1 and cytotoxic T lymphocyte-associated antigen-4 inhibitors, could also stand to benefit patients with metastatic conjunctival melanoma. Limited case reports provide clues about the effectiveness of both targeted small-molecule inhibitors and immunotherapy in patients with advanced local and metastatic conjunctival melanoma and give credence to the argument that conjunctival melanoma patients should be included in major trials studying new therapies in both cutaneous and mucosal melanomas where applicable.
Collapse
|
32
|
Trager MH, Ensslin CE, Fan W, Samie FH. Factors impacting patient ratings of Mohs micrographic surgeons: Lessons gleaned from analysis of 17,527 online reviews. J Am Acad Dermatol 2020; 83:1825-1827. [PMID: 32450101 DOI: 10.1016/j.jaad.2020.05.082] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2020] [Revised: 04/20/2020] [Accepted: 05/16/2020] [Indexed: 11/16/2022]
Affiliation(s)
- Megan H Trager
- Vagelos College of Physicians and Surgeons, Columbia University, New York, New York
| | - Courtney E Ensslin
- Department of Dermatology, Irving Medical Center, Columbia University, New York, New York
| | - Weijia Fan
- Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Irving Medical Center, Columbia University, New York, New York.
| |
Collapse
|
33
|
Geskin LJ, Trager MH, Aasi SZ, Bickers DR, Carvajal RD, Nghiem P, Taback B, Zeitouni NC, Samie FH. Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic. J Am Acad Dermatol 2020; 83:295-296. [PMID: 32387656 PMCID: PMC7202818 DOI: 10.1016/j.jaad.2020.05.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 04/30/2020] [Accepted: 05/01/2020] [Indexed: 12/04/2022]
Affiliation(s)
- Larisa J Geskin
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
| | - Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Sumaira Z Aasi
- Department of Dermatology, Stanford Medicine, Stanford, California
| | - David R Bickers
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Richard D Carvajal
- Division of Hematology, Department of Medicine, Columbia University Irving Medical Center, New York, New York
| | - Paul Nghiem
- Department of Dermatology, University of Washington Medical Center, Seattle, Washington
| | - Bret Taback
- Department of Surgery, Columbia University Irving Medical Center, New York, New York
| | - Nathalie C Zeitouni
- Department of Dermatology, University of Arizona College of Medicine, Phoenix, Arizona
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| |
Collapse
|
34
|
Trager MH, Queen D, Samie FH, Carvajal RD, Bickers DR, Geskin LJ. Advances in Prevention and Surveillance of Cutaneous Malignancies. Am J Med 2020; 133:417-423. [PMID: 31712100 PMCID: PMC7709483 DOI: 10.1016/j.amjmed.2019.10.008] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Revised: 10/10/2019] [Accepted: 10/21/2019] [Indexed: 12/16/2022]
Abstract
Skin cancer affects 1 in 5 Americans, resulting in significant morbidity and mortality. Treatment costs and rates of skin cancer and melanoma continue to rise, making preventative measures increasingly important. However, there is conflicting evidence about efficacy of primary and secondary prevention strategies in decreasing incidence and improving early diagnosis. The US Preventative Services Task Force 2016 guidelines did not endorse routine skin cancer screening because of "insufficient evidence." Yet, countries like Australia have shown the feasibility and cost-effectiveness of primary sun safety interventions and secondary prevention measures such as routine skin cancer surveillance. Additional emerging evidence shows that regular skin cancer screening in high-risk populations improves early detection and decreases melanoma mortality. New technology may enhance prevention, promote accurate diagnoses, and improve management of melanoma and nonmelanoma skin cancers. Here, we place rising rates of melanoma within historical context, review costs, efficacy, and evidence for primary and secondary skin cancer prevention and examine the evolving role of novel technologies in the field.
Collapse
Affiliation(s)
- Megan H Trager
- Vagelos College of Physicians and Surgeons, Columbia University, New York
| | - Dawn Queen
- Vagelos College of Physicians and Surgeons, Columbia University, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York
| | - Richard D Carvajal
- Department of Hematology/Oncology, Columbia University Irving Medical Center New York
| | - David R Bickers
- Department of Dermatology, Columbia University Irving Medical Center, New York
| | - Larisa J Geskin
- Department of Dermatology, Columbia University Irving Medical Center, New York.
| |
Collapse
|
35
|
McLawhorn JM, Stephany MP, Bruhn WE, Crow LD, Coldiron BM, Hruza GJ, Leach BC, Soon SL, Friedmann DP, Stebbins WG, Blalock TW, Graves MS, Billingsley EM, Knackstedt TJ, Miller SJ, Yob EH, Albertini JG, Zeitouni N, Krathen RA, Bichakjian CK, Jellinek NJ, Hanke CW, Samie FH, Mann MW, Carucci JA, Kakar R, Saylor DK, Fosko SW, Ortiz AE, Henghold WB, Jennings TA, Davis DS, Maloney ME, Curcio NM, Behshad R, Tope WD, McCoppin H, Levin JI, Collins L, Stasko T. An expert panel consensus on opioid-prescribing guidelines for dermatologic procedures. J Am Acad Dermatol 2020; 82:700-708. [DOI: 10.1016/j.jaad.2019.09.080] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2019] [Revised: 09/23/2019] [Accepted: 09/26/2019] [Indexed: 10/25/2022]
|
36
|
Behbahani S, Malerba S, Karanfilian KM, Warren CJ, Alhatem A, Samie FH. Demographics and outcomes of eccrine porocarcinoma: results from the National Cancer Database. Br J Dermatol 2020; 183:161-163. [PMID: 31954060 DOI: 10.1111/bjd.18874] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S Behbahani
- Rutgers New Jersey Medical School, Newark, NJ, U.S.A
| | - S Malerba
- Rutgers New Jersey Medical School, Newark, NJ, U.S.A
| | | | - C J Warren
- Rutgers New Jersey Medical School, Newark, NJ, U.S.A
| | - A Alhatem
- Department of Pathology and Laboratory, Rutgers New Jersey Medical School, Newark, NJ, U.S.A
| | - F H Samie
- Department of Dermatology, Columbia University Irving Medical Centre, New York, NY, U.S.A
| |
Collapse
|
37
|
Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol 2019; 20:e699-e714. [DOI: 10.1016/s1470-2045(19)30673-4] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2019] [Revised: 09/12/2019] [Accepted: 09/13/2019] [Indexed: 12/18/2022]
|
38
|
Crow LD, Jambusaria‐Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, Brodland DG, Brown MR, Carroll BT, Carucci JA, Chang TW, Chaux G, Cusack CA, Dilling DF, Doyle A, Emtiazjoo AM, Ferguson NH, Fosko SW, Fox MC, Goral S, Gray AL, Griffin JR, Hachem RR, Hall SA, Hanlon AM, Hayes D, Hickey GW, Holtz J, Hopkins RS, Hu J, Huang CC, Brian Jiang SI, Kapnadak SG, Kraus ES, Lease ED, Leca N, Lee JC, Leitenberger JJ, Lim MA, Longo MI, Malik SM, Mallea JM, Menter A, Myers SA, Neuburg M, Nijhawan RI, Norman DJ, Otley CC, Paek SY, Parulekar AD, Patel MJ, Patel VA, Patton TJ, Pugliano‐Mauro M, Ranganna K, Ravichandran AK, Redenius R, Roll GR, Samie FH, Shin T, Singer JP, Singh P, Soon SL, Soriano T, Squires R, Stasko T, Stein JA, Taler SJ, Terrault NA, Thomas CP, Tokman S, Tomic R, Twigg AR, Wigger MA, Zeitouni NC, Arron ST. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transpl Int 2019; 32:1268-1276. [DOI: 10.1111/tri.13520] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Revised: 03/25/2019] [Accepted: 09/02/2019] [Indexed: 12/25/2022]
|
39
|
Queen D, Fisher J, Husain S, Linos K, Niedt GW, Samie FH. Cutaneous metastasis of hepatocellular carcinoma following liver transplantation. J Cutan Pathol 2019; 47:47-51. [PMID: 31381162 DOI: 10.1111/cup.13555] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2019] [Revised: 06/09/2019] [Accepted: 07/29/2019] [Indexed: 11/28/2022]
Abstract
Cutaneous metastases from hepatocellular carcinoma (HCC) are extremely rare and can represent a sign of an underlying malignancy or relapse/progression from an existing tumor. We report a case of a cutaneous metastasis arising in a patient with metastatic HCC following orthotopic liver transplantation. Diagnosis is a multistep process as cutaneous HCC metastases must be differentiated from primary cutaneous malignancies as well as other cutaneous metastases. Making this even more challenging, HCC metastases have heterogeneous clinical and histologic appearances. Therefore, the use of immunohistochemical stains, including hepatocyte paraffin-1, arginase-1, and glypican-3, and correlation with the clinical context are essential for a correct diagnosis.
Collapse
Affiliation(s)
- Dawn Queen
- Columbia University Vagelos College of Physicians and Surgeons, New York, New York
| | - Juliya Fisher
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Sameera Husain
- Department of Pathology, Columbia University Irving Medical Center, New York, New York
| | - Konstantinos Linos
- Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.,Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
| | - George W Niedt
- Department of Pathology, Columbia University Irving Medical Center, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| |
Collapse
|
40
|
Lopez AT, Fisher J, Samie FH. Fall risk assessment and injury prevention in the Mohs surgery clinic: a review of the literature and recommendations for improving patient safety. Dermatol Online J 2019; 25:13030/qt19h4m2kg. [PMID: 31553857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Accepted: 09/09/2019] [Indexed: 06/10/2023] Open
Abstract
UNLABELLED Patient falls remain a major cause of adverse events in the medical setting. Many patients receiving Mohs micrographic surgery are at high risk, both for falling and resultant injuries. Although the incidence of patient falls in dermatologic surgery is low, falls can have significant consequences for both patient and provider. Therefore, effective interventions to improve organizational safety are critical. Though there is a considerable amount of research pertaining to fall prevention strategies, the majority of studies have been confined to the inpatient setting and long-term care facilities. Implementation of fall prevention initiatives in the outpatient setting has rarely been evaluated and no studies have focused on the Mohs patient population to date. METHODS We reviewed the literature pertaining to fall risk and prevention guidelines in the inpatient and outpatient settings as it applies to the dermatologic surgery environment. RESULTS Herein we will discuss patient risk factors for falling relevant to the Mohs setting and review existing validated fall risk assessment tools and strategies for fall prevention. CONCLUSION Identifying fall risk factors can improve patient safety and reduce falls in the dermatologic surgery clinic.
Collapse
Affiliation(s)
| | | | - Faramarz H Samie
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY Department of Dermatology, Columbia University Medical Center, New York, NY.
| |
Collapse
|
41
|
Samie FH. JAAD Game Changers∗: Surgeon error and slide quality during Mohs micrographic surgery: Is there a relationship with tumor recurrence? J Am Acad Dermatol 2019; 85:538. [PMID: 31129221 DOI: 10.1016/j.jaad.2019.05.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2019] [Accepted: 05/16/2019] [Indexed: 10/26/2022]
|
42
|
Samie FH. JAAD Game Changers∗: Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides. J Am Acad Dermatol 2019; 85:537. [PMID: 31129220 DOI: 10.1016/j.jaad.2019.05.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2019] [Accepted: 05/16/2019] [Indexed: 11/25/2022]
|
43
|
Lopez AT, Fisher J, Samie FH. Fall risk assessment and injury prevention in the Mohs surgery clinic: a review of the literature and recommendations for improving patient safety. Dermatol Online J 2019. [DOI: 10.5070/d3258045122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
44
|
Queen D, Knackstedt T, Polacco MA, Collins LK, Lee K, Samie FH. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery. J Eur Acad Dermatol Venereol 2018; 33:305-311. [PMID: 30284728 DOI: 10.1111/jdv.15263] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Accepted: 08/27/2018] [Indexed: 01/18/2023]
Abstract
BACKGROUND The lip and surrounding perioral region are susceptible to non-melanoma skin cancer, but the distribution of basal cell and squamous cell carcinoma on the cutaneous and vermilion lips has not been fully elucidated. OBJECTIVE To investigate the distribution of cutaneous and vermilion lip non-melanoma skin cancer and to better describe risk factors, anatomic location, treatment characteristics and oncologic outcomes. METHODS A retrospective comparative case series of patients undergoing Mohs micrographic surgery (MMS) at a single academic centre for lip and perioral basal cell and squamous cell carcinoma was performed over a 5-year period. Demographics, medical comorbidities, surgical characteristics and recurrence status were extracted. RESULTS Forty-five vermilion and 116 cutaneous lip cancers were identified. Basal cell carcinoma (BCC) was more common in the cutaneous perioral region, while squamous cell carcinoma (SCC) was more common on the vermilion lip (P < 0.001). BCCs were more common on the upper vermilion lip and SCCs were more common on the lower vermilion lip (P < 0.001). Within the cutaneous perioral region, both BCCs and SCCs were more common on the upper perioral surface (P = 0.002). Male gender was associated with lower lip SCC (P = 0.015). Smoking, immunosuppression, anticoagulant use and hydrochlorothiazide use were not associated with cancer type or location. Recurrences were rare, but more common in vermilion lip cancers (6.6%) compared to perioral cutaneous cancers (0.8%). Outcomes for all groups were similar; BCCs of the vermilion lip had significantly greater mean MMS stages (P < 0.001) as did SCCs (P = 0.05). CONCLUSION Basal cell carcinoma is more commonly encountered on the cutaneous lip, whereas SCC is more common on the vermilion lip. Within the vermilion lip, BCC favours the upper lip, while SCC favours the lower lip. Within the cutaneous perioral region, both BCC and SCC favour the upper cutaneous tissue. Early stage lip cancers are curable by Mohs micrographic surgery with rare recurrences.
Collapse
Affiliation(s)
- D Queen
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
| | - T Knackstedt
- Department of Dermatology, Cleveland Clinic Foundation, Cleveland, OH, USA
| | - M A Polacco
- Section of Otolaryngology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
| | - L K Collins
- Section of Dermatology, Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
| | - K Lee
- Department of Dermatology, The Warren Alpert Medical School at Brown University, Providence, RI, USA
| | - F H Samie
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.,Section of Dermatology, Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.,Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| |
Collapse
|
45
|
Filitis DC, Fisher J, Samie FH. Reconstruction of a surgical defect in the popliteal fossa: A case report. Int J Surg Case Rep 2018; 53:228-230. [PMID: 30428437 PMCID: PMC6232581 DOI: 10.1016/j.ijscr.2018.10.070] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2018] [Revised: 10/22/2018] [Accepted: 10/24/2018] [Indexed: 11/10/2022] Open
Abstract
Popliteal tumors and their associated defects present the dermatologic surgeon with rare and unique surgical and reconstruction challenges. When planning reconstruction in the popliteal fossa, prolonged wound care and functional impairment are concerns. In such an area with little tissue laxity, a random patterned bilobed with an undersized secondary lobe is an excellent solution to this challenge.
Introduction Surgical defects of the popliteal fossa pose a reconstructive challenge to the surgeon, given the intimate relationship of this area with the knee joint and underlying vital neuro-vasculature. Case presentation An 88-year-old woman was treated for a biopsy proven invasive squamous cell carcinoma of the right popliteal fossa with Mohs micrographic surgery. The resultant defect (4.5 × 4.3 cm) was repaired using a random patterned bilobed flap with an undersized secondary lobe and porcine xenograft with excellent functional and cosmetic outcome. Discussion Numerous approaches to reconstruction of the popliteal fossa have been proposed, including primary closure, secondary intent healing, skin grafting, random flaps, muscle flaps, fasciocutaneous flaps, freeflaps, and tissue expansion. Sub-optimal repair of the popliteal fossa can reduce mobility of the knee joint, carry a high risk of wound dehiscence and may result in significant scarring. Here, we present the use of a bilobed flap with an undersized secondary lobe, in a patient with limited tissue laxity, for the repair of the popliteal fossa. Conclusion Utilizing a random pattern bilobed flap with an undersized secondary lobe is an excellent alternative for the repair of moderate sized popliteal fossa defects.
Collapse
Affiliation(s)
- Dan C Filitis
- Columbia University Medical Center, Department of Dermatology, New York, NY, 10032, United States
| | - Juliya Fisher
- Columbia University Medical Center, Department of Dermatology, New York, NY, 10032, United States
| | - Faramarz H Samie
- Columbia University Medical Center, Department of Dermatology, New York, NY, 10032, United States.
| |
Collapse
|
46
|
Bayan CAY, Khanna T, Rotemberg V, Samie FH, Zeitouni NC. A review of non-invasive imaging in extramammary Paget's disease. J Eur Acad Dermatol Venereol 2018; 32:1862-1873. [PMID: 29763511 DOI: 10.1111/jdv.15072] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2017] [Accepted: 04/30/2018] [Indexed: 01/04/2023]
Abstract
Extramammary Paget's Disease (EMPD) is a rare intraepithelial adenocarcinoma that classically manifests with pruritic, erythematous and scaling plaques. The clinical picture frequently mimics inflammatory or infectious conditions and is thus commonly misdiagnosed. The assessment of tumour margins is equally challenging as tumours have a propensity to spread beyond clinically visible boundaries. Appropriate non-invasive diagnostic tools can assist in the early detection, diagnosis and management of EMPD. This paper will review the literature on non-invasive imaging modalities used in EMPD. Articles from the PubMed database were selected based on relevance to the topic of this review. Articles that were not specific to EMPD and non-invasive imaging were excluded. Search strategy is further described in the methods section below. Eighteen articles were selected for this review: six PET/CT, five reflectance confocal microscopy (RCM), two photodynamic diagnosis (PDD), two dermoscopy, two MRI and one optical coherence tomography (OCT) paper(s). Dermoscopy, PDD, RCM and OCT can help to distinguish malignant conditions, including EMPD, from benign conditions. RCM and OCT can identify atypical cells in real-time, and have the potential to improve the accuracy of surgical margins intraoperatively and overall management. Distinctive confocal characteristics of EMPD have been described using RCM. The sensitivity and specificity of these findings require additional validation. Radiographic techniques also play a central role in the diagnosis of EMPD and assessment of disease spread. PET/CT and MRI can detect primary disease, nodal and distant metastases, with superior delineation of disease spread on MRI. Limitations of PET/CT are mainly related to primary tumour thickness, and size and FDG-avidity of nodal and distant metastases. Limitations of MRI include the fact that few studies have examined its use in EMPD; additional research is warranted. Randomized controlled trials and large prospective studies evaluating the use of non-invasive imaging in EMPD are needed.
Collapse
Affiliation(s)
- C-A Y Bayan
- Columbia University College of Physicians and Surgeons, New York, NY, USA
| | - T Khanna
- Columbia University College of Physicians and Surgeons, New York, NY, USA
| | - V Rotemberg
- Department of Dermatology, Columbia University Medical Center, New York, NY, USA
| | - F H Samie
- Department of Dermatology, Columbia University Medical Center, New York, NY, USA
| | - N C Zeitouni
- Department of Dermatology, University of Arizona and University of Arizona Cancer Center at Dignity Health, Phoenix, AZ, USA
| |
Collapse
|
47
|
Fontecilla NM, Kittler NW, Geskin L, Samie FH, Niedt G, Imahiyerobo T, Schwartz G, Ingham M, Lewin JM. Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery. JAAD Case Rep 2017; 3:467-469. [PMID: 28971134 PMCID: PMC5614636 DOI: 10.1016/j.jdcr.2017.06.019] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Affiliation(s)
| | - Nicole W Kittler
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - Larisa Geskin
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Medical Center, New York, New York
| | - George Niedt
- Department of Dermatopathology, Columbia University Medical Center, New York, New York
| | - Thomas Imahiyerobo
- Department of Plastic Surgery, Columbia University Medical Center, New York, New York
| | - Gary Schwartz
- Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center, New York, New York
| | - Matt Ingham
- Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center, New York, New York
| | - Jesse M Lewin
- Department of Dermatology, Columbia University Medical Center, New York, New York
| |
Collapse
|
48
|
Filitis DC, Paragh G, Samie FH, Zeitouni NC. Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report. BMC Res Notes 2017; 10:490. [PMID: 28931417 PMCID: PMC5607566 DOI: 10.1186/s13104-017-2746-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Accepted: 08/21/2017] [Indexed: 11/10/2022] Open
Abstract
Background The National Comprehensive Cancer Network guidelines for Merkel cell carcinoma recommend performance of the sentinel lymph node biopsy in all patients with clinically negative nodal disease for staging and treatment. Nevertheless, sentinel lymph node biopsy in the periocular region is debated as tumors are typically smaller and lymphatic variability can make performance procedurally problematic. Case presentation We present a case of a Caucasian patient in their seventies who presented with a 1.0 cm periocular Merkel cell carcinoma, who underwent Mohs surgery with a Tenzel flap repair, that was found to have a positive sentinel lymph node biopsy, but who, despite parotidectomy, selective neck dissection, and radiation, succumbed to the disease. Conclusions Evidence in both the site-specific and non-specific literature demonstrates: (1) Worsening prognosis with extent of lymph node burden, (2) improvements in our abilities to perform lymphoscintigraphy, (3) locoregional and distant metastatic disease in patients with tumor sizes ≤1 cm, and (4) significant rates of sentinel lymph node positivity in patients with tumor sizes ≤1 cm. Our case supports that sentinel lymph node biopsy should be considered in all clinically nodal negative periocular Merkel cell carcinoma, regardless of size, and despite limited site-specific studies on the subject.
Collapse
Affiliation(s)
- Dan C Filitis
- Department of Dermatology, Columbia University Medical Center, 161 Fort Washington Avenue, 12th Floor, New York, NY, 10032, USA.
| | - Gyorgy Paragh
- Department of Dermatology, Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, USA
| | - Faramarz H Samie
- Department of Dermatology, Columbia University Medical Center, 161 Fort Washington Avenue, 12th Floor, New York, NY, 10032, USA.,Columbia University Medical Center, New York, USA
| | - Nathalie C Zeitouni
- University of Arizona COM Phoenix, University of Arizona Cancer Center at Dignity Health, 625 N 6th Street, Phoenix, AZ, 85004, USA
| |
Collapse
|
49
|
Abstract
Previous scar scales have focused on verbal descriptions. A nonverbal visual assessment tool would provide a simple way for patients and physicians to quantify scar appearance. The authors sought to use a validated visual assessment tool for linear surgical scars to assess linear scars on the face and to determine whether patients and surgeons rate scars similarly. A total of 143 patients with linear facial scars resulting from repair of Mohs micrographic surgery defects used the visual assessment tool to rate their surgical scar. Six physicians used the tool to rate a subset of the patients' scar photographs. The scar ratings for patients and physicians were compared. Among the scars rated by both the patients and physicians (n = 79), patients had a significantly lower mean (i.e., more favorable) rating compared with the physicians. This was a single-center study including only Caucasian patients. The visual assessment tool to rate linear surgical scars provided a simple method for both patients and physicians to assess the overall appearance of postsurgical scars. Difference in the scar ranking between patients and physicians indicate the importance of incorporating both patient and physician point of view when assessing scars.
Collapse
Affiliation(s)
- Lindsey K Collins
- Department of Surgery, Section of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | | | - Pamela Ganger
- Department of Surgery, Section of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | - Emily Scherer
- Department of Biomedical Data Science, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | - Faramarz H Samie
- Department of Surgery, Section of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| |
Collapse
|
50
|
Collins LK, Chapman MS, Carter JB, Samie FH. Cutaneous adverse effects of the immune checkpoint inhibitors. Curr Probl Cancer 2016; 41:125-128. [PMID: 28190531 DOI: 10.1016/j.currproblcancer.2016.12.001] [Citation(s) in RCA: 130] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2016] [Accepted: 12/10/2016] [Indexed: 10/20/2022]
Abstract
The immune checkpoint targeted agents, anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and anti-programed cell death 1 (PD-1) or anti-programmed death ligand 1 (PD-L1) inhibitors are frequently associated with cutaneous side effects that are often dose limiting and can lead to discontinuation of therapy. Ipilimumab, a CTLA-4 inhibitor, is most commonly associated with a morbilliform eruption on the trunk and extremities and pruritus. More severe cutaneous toxicities reported include toxic epidermal necrolysis and severe drug rash with eosinophila and systemic symptoms. Recent case reports of Sweet syndrome and cutaneous sarcoidosis have also recently been described after treatment with ipilimumab. The cutaneous events usually occur early in the course of treatment and are dose dependent. PD-1 inhibitors, nivolumab and pembrolizumab, induce similar but less severe toxicities compared with the CTLA-4 inhibitors. The most common cutaneous adverse events include lichenoid reactions, eczema, vitiligo, and pruritus. Lichenoid oral mucosal lesions located on the tongue, buccal mucosa, lips, or gingivae or located on all of these have also recently been described. The time of onset of the cutaneous events with the PD-1 inhibitors occurs later than that seen with the CTLA-4 inhibitors. Anti-PD-L1 antibodies, such as atezolizumab, have a similar side effect profile compared with the PD-1 inhibitors. Combination of immune checkpoint inhibitors, ipilimumab and nivolumab, has recently been approved for the treatment of advanced melanoma. The combination therapy is associated with a more severe side effect profile compared with the agents used as monotherapy. We discuss the most frequently encountered cutaneous side effects of the immune checkpoint inhibitors and review the recommended management strategies.
Collapse
Affiliation(s)
- Lindsey K Collins
- Section of Dermatology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
| | - M Shane Chapman
- Section of Dermatology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire
| | - Joi B Carter
- Section of Dermatology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire
| | - Faramarz H Samie
- Section of Dermatology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire
| |
Collapse
|